Risk Factors for Poor Adherence to Eyedrops in Electronically Monitored Patients with Glaucoma

Ophthalmology

Volumn 116, Issue 6, 2009, Pages 1097-1105

  Friedman, David S ^a,b   Okeke, Constance O ^c   Jampel, Henry D ^a   Ying, Gui shuang ^c   Plyler, Ryan J ^a   Jiang, Yuzhen ^d   Quigley, Harry A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRAVOPROST;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DEPRESSION; DOSING AID; ELECTRONICS; FEMALE; FOLLOW UP; GLAUCOMA; HEALTH BELIEF; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CLOPROSTENOL; DRUG MONITORING; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTRAOCULAR PRESSURE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS;

EID: 67349227964     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.01.021     Document Type: Article

References (30)

1. Cramer J.A., Mattson R.H., Prevey M.L., et al. How often is medication taken as prescribed?. A novel assessment technique. JAMA 261 (1989) 3273-3277
2. Haynes R.B., McDonald H.P., and Garg A.X. Helping patients follow prescribed treatment: clinical applications. JAMA 288 (2002) 2880-2883
3. Haynes R.B., Yao X., Degani A., et al. Interventions to enhance medication adherence. Cochrane Database Syst Rev 4 (2005) CD000011
4. Haynes R.B., McDonald H.P., Garg A.X., and Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2 (2002) CD000011
5. DiMatteo M.R., Giordani P.J., Lepper H.S., and Croghan T.W. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40 (2002) 794-811
6. DiMatteo M.R. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 42 (2004) 200-209
7. Knight K.M., McGowan L., Dickens C., and Bundy C. A systematic review of motivational interviewing in physical health care settings. Br J Health Psychol 11 (2006) 319-332
8. In: Sabate E. (Ed). Adherence to long-term therapies: evidence for action (2003), World Health Organization, Geneva 48-89. http://whqlibdoc.who.int/publications/2003/9241545992.pdf Accessed August 1, 2008
9. Olthoff C.M., Schouten J.S., van de Borne B.W., and Webers C.A. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review. Ophthalmology 112 (2005) 953-961
10. Nordstrom B.L., Friedman D.S., Mozaffari E., et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 140 (2005) 598-606
11. Schwartz G.F., Reardon G., and Mozaffari E. Persistency with latanoprost or timolol in primary open-angle glaucoma suspects. Am J Ophthalmol 137 suppl (2004) S13-S16
12. Kass M.A., Gordon M., and Meltzer D.W. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?. Am J Ophthalmol 101 (1986) 524-530
13. Norell S.E. Accuracy of patient interviews and estimates by clinical staff in determining medication compliance. Soc Sci Med [E] 15 (1981) 57-61
14. Okeke C.O., Quigley H.A., Jampel H.D., et al. Adherence with topical glaucoma medication monitored electronically: the travatan dosing aid study. Ophthalmology 116 (2009) 191-199
15. Becker M.H., and Maiman L.A. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 13 (1975) 10-24
16. Osterberg L., and Blaschke T. Adherence to medication. N Engl J Med 353 (2005) 487-497
17. Friedman D.S., Hahn S.R., Gelb L., et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma: results from the Glaucoma Adherence and Persistence Study. Ophthalmology 115 (2008) 1320-1327 1327.31-3
18. Friedman D.S., Quigley H.A., Gelb L., et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci 48 (2007) 5052-5057
19. Quigley H.A., Friedman D.S., and Hahn S.R. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study. Ophthalmology 114 (2007) 1599-1606
20. Farmer K.C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21 (1999) 1074-1090
21. McHorney C.A., Ware Jr. J.E., and Raczek A.E. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31 (1993) 247-263
22. Ross C.E., and Mirowsky J. Components of depressed mood in married men and women: the Center for Epidemiologic Studies' Depression Scale. Am J Epidemiol 119 (1984) 997-1004
23. Feldman S.R., Camacho F.T., Krejci-Manwaring J., et al. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 57 (2007) 81-83
24. Friedman D.S., Jampel H.D., Congdon N.G., et al. The TRAVATAN dosing aid accurately records when drops are taken. Am J Ophthalmol 143 (2007) 699-701
25. Kass M.A., Meltzer D.W., Gordon M., et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol 101 (1986) 515-523
26. Kaplan R.C., Bhalodkar N.C., Brown Jr. E.J., et al. Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Prev Med 39 (2004) 1249-1255
27. Cooper L.A., Beach M.C., Johnson R.L., and Inui T.S. Delving below the surface: understanding how race and ethnicity influence relationships in health care. J Gen Intern Med 21 suppl (2006) S21-S27
28. Ziegelstein R.C., Fauerbach J.A., Stevens S.S., et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 160 (2000) 1818-1823
29. Wang P.S., Bohn R.L., Knight E., et al. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 17 (2002) 504-511
30. Kim E.Y., Han H.R., Jeong S., et al. Does knowledge matter?. Intentional medication nonadherence among middle-aged Korean Americans with high blood pressure. J Cardiovasc Nurs 22 (2007) 397-404